Evaluation of the three-hour oral glucose tolerance test in detection of significant hyperglycemia and hypoglycemia in pregnancy.

Analysis of 2,000 consecutive patients who had a three-hour 50-gm. oral glucose tolerance test done in the third trimester of pregnancy has shown that the three-hour reading was not necessary for the diagnosis of gestational diabetes. It was found that hyperglycemia and hypoglycemia (95th and 5th percentiles, respectively, for plasma glucose levels) were significantly associated with an increased risk for perinatal mortality. Furthermore, hyperglycemia was associated with an increased incidence of large-for-dates placentas and hypoglycemia with small-for-dates infants and small-for-dates placentas. These associations with hypoglycemia were seen to be greatest when this occurred at the three-hour level, and it was concluded that the three-hour measurement should be retained until the clinical significance of hypoglycemia in pregnancy is fully determined.

Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia.

Gestational diabetes mellitus (GDM) was diagnosed in 1928 of 35,253 (5.5%) tested pregnancies at the Mercy Maternity Hospital in Melbourne between 1979 and the end of 1988. Compared with women born in Australia and New Zealand, the incidence of GDM was significantly greater in women born on the Indian subcontinent (15%); in women born in Africa (9.4%), Vietnam (7.3%), Mediterranean countries (7.3%), and Egypt and Arabic countries (7.2%); and in Chinese (13.9%) and other Asian (10.9%) women. There was no significant difference for women born in the United Kingdom and northern Europe (5.2%), Oceania (5.7%), North America (4.0%), or South America (2.2%). With the World Health Organization criteria as a guide to the severity of hyperglycemia, compared with mothers born in Australia and New Zealand, there were significant increases in the incidences of the more severe grades of GDM in parturients born in the Mediterranean region, Asia, the Indian subcontinent, Egypt, and Arabic countries. The incidence of GDM increased significantly in all racial groups, rising from 3.3% during 1979-1983 to 7.5% during 1984-1988.

Effect of follow-up of women with gestational diabetes on the ratio of IDDM to NIDDM in pregnancy.

OBJECTIVE: We wished to test the hypothesis that the diagnosis of diabetes in women with previous gestational diabetes in our follow-up program had altered the ratio of IDDM to NIDDM in our pregnant population. RESEARCH DESIGN AND METHODS: We identified all pregnancies managed at the Mercy Hospital for Women in Melbourne, Australia, from 1971 to 1994 that were complicated by prepregnancy diabetes. In these 374 pregnancies, we identified those women who had previously been diagnosed with gestational diabetes mellitus (GDM). The changing prevalences over time of prepregnancy IDDM and NIDDM, as well as the contribution to both of these conditions made by women who had previously had GDM, were calculated. RESULTS: Over the period of the study, there was an increase in the prevalence of IDDM from 0.15 to 0.44% (chi 2 for trend, P < 0.00001) and NIDDM from 0.03 to 0.11% (chi 2 for trend, P = 0.0001). The proportion of all women with diabetes with NIDDM did not change significantly (16.7-20%). There was a progressive increase in the proportion of women with NIDDM who had had GDM (from 8.3 to 39.1%), but the trend was not statistically significant (P = 0.059). Women with NIDDM were more likely (20 of 64, 31.3%) to have had gestational diabetes in the past than women with IDDM (12 of 310, 3.9%, odds ratio 11.3, 95% CI 5.16-24.7, P < 0.0001). CONCLUSIONS: Despite finding relatively young women to have NIDDM, our GDM follow-up clinic has not yet altered significantly the ratio of IDDM to NIDDM in pregnancy.

Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy.

OBJECTIVE: To determine the value of measuring serum triglyceride (TG) levels early in pregnancy for predicting late-gestation glucose tolerance and neonatal birth weight ratio (BWR) (birth weight corrected for gestational age). RESEARCH DESIGN AND METHODS: The relationships between morning nonfasting TG measured early in pregnancy (gestational age 12 +/- 6 weeks [mean +/- SD]) and glucose tolerance measured by a 3-h 50-g oral glucose tolerance test (OGTT) late in pregnancy (gestational age 30 +/- 3 weeks) and BWR were investigated in 388 women attending routine antenatal care. The data were analyzed for all women in addition to subgroups of Australian/Western European-born (n = 246) and Asian-born (n = 97) women. RESULTS: Morning nonfasting TG positively correlated with the OGTT glucose area under the curve (OGTT-GAUC) (r = 0.23, P < 0.0001) in all subjects. This correlation was stronger in the subset of subjects who had TG measured between 9 and 12 weeks of gestation (r = 0.35, P = 0.0001) and was particularly strong in Asian-born women who had TG measured within this period (r = 0.71, P < 0.0001). Mean TG and the 2- and 3-h OGTT values were higher in Asian-born subjects compared with Australian/Western European-born subjects (P = 0.004, P < 0.0001, and P = 0.02, respectively). TG correlated positively with BWR in all subjects (r = 0.12, P = 0.02), in Asian-born subjects (r = 0.23, P = 0.02), and in subjects with gestational diabetes mellitus (GDM) (r = 0.60, P = < 0.001). CONCLUSIONS: TG, if measured between 9 and 12 weeks of gestation, has moderate predictive value for subsequent glucose tolerance in pregnancy. TG is also predictive of BWR in GDM subjects. Further studies are warranted to investigate the role of early TG measurement in the screening and management of GDM. Metabolic heterogeneity exists between Asian-born and Australian/Western European-born women, the significance of which is still unclear and warrants further study.

Maternal glucose tolerance and obstetric complications in pregnancies in which the offspring developed type I diabetes.

OBJECTIVE: To identify possible in utero risk factors in children who develop type I diabetes and to determine the risk of development of type I diabetes in the children of women with gestational diabetes. RESEARCH DESIGN AND METHODS: All known children with type I diabetes born at the Mercy Hospital for Women whose mothers had glucose tolerance tests (GTTs) performed during pregnancy were identified. The results of the mothers' GTTs were compared with those of the hospital population, as were their obstetric complications. RESULTS: We identified 38 children with type I diabetes born at this hospital whose mothers had GTTs performed during pregnancy. Only one of these mothers had gestational diabetes, compared with 5.6% in the overall hospital population (adjusted odds ratio 0.69, 95% confidence interval 0.12-3.84, P = 0.99). There were no differences in the blood glucose levels between the mothers of the children who developed diabetes and the general hospital population. The birth weights of the children destined to develop diabetes also showed no deviation from the expected distribution, and there were no outstanding features of the mothers' obstetric histories. CONCLUSIONS: Maternal blood glucose level is not an important determinant of the child's risk of developing type I diabetes.

Linea alba pigmentation and umbilical deviation in nulliparous pregnancy: the ligamentum teres sign.

OBJECTIVE: To determine the incidence and direction of umbilical deviation in pregnancy at term in nulliparas with linea alba pigmentation. METHODS: All women attending one prenatal clinic over a period of 19 months were available. Subjects studied were the 315 nulliparas whose pregnancies had reached at least 37 weeks' gestation. The presence of linea alba pigmentation, with or without umbilical flattening and/or deviation, was assessed with the woman lying symmetrically on her back on an examination couch. RESULTS: Forty-four of the 315 women (14%) had sufficient pigmentation for assessment; 27 of the 44 (61.4%) were born in Asia or the Indian subcontinent, although such women comprised only 13.5% of the clinic population. In 31 of the 44 women (70.5%), the umbilicus and supra- or infraumbilical linea nigra was deviated to the right side, and in 13 it remained in the midline; in none was there deviation to the left side. CONCLUSION: Displacement of the umbilicus and adjacent structures commonly occurs in term pregnancy; pressure of the uterus on the ligamentum teres and falciform ligament determines that displacement is invariably toward the right side.

The persistence of abnormal glucose tolerance after delivery.

In the first 7 days after delivery, 270 women who had gestational diabetes and 100 who had normal prenatal glucose tolerance were retested for glucose intolerance. In the group who had gestational diabetes, glucose tolerance remained abnormal by the Mercy Maternity Hospital criterion in 28% of those who had been delivered vaginally and in 43% of those delivered by cesarean. The only abnormal test in the control group was in one of the two women delivered by cesarean, and this test returned to normal by the seventh postoperative day. By 6 weeks postpartum, the incidence of abnormal glucose tolerance was 24 and 30% for patients having vaginal and abdominal deliveries, respectively. The method of infant feeding had no significant influence on the prevalence of abnormal glucose tolerance. We conclude that if a glucose tolerance test has not been performed prenatally, the test is still worthwhile in the immediate puerperium if the possibility of gestational diabetes has been raised by adverse pregnancy outcome, because about one in three diabetics will be thus identified. However, screening in the puerperium is not a substitute for prenatal screening.

Congenital malformations, abnormal glucose tolerance, and estriol excretion in pregnancy.

Study of 10,454 consecutive newborn infants showed that 4.1% had a major malformation and 6.5% had a minor malformation. The incidence of major fetal malformations was increased in stillborn infants (14.1%), neonatal deaths (36.7%), and dysmature infants (8.6%), and when there was maternal hypoglycemia (5.8%, hyperglycemia (5.8%), or subnormal urinary estriol excretion (9.8%). Minor malformations were associated with fetal dysmaturity (9.7%) and subnormal estriol excretion (8.8%). Abnormalities of maternal glucose tolerance and urinary estriol excretion were associated with specific types of major malformations. These data showed that hypoglycemia was as important as hyperglycemia in the etiology of fetal malformations.

Maternal glucose tolerance during pregnancy with excessive size infants.

A study of maternal glucose tolerance conducted during 137 pregnancies in which the infant weighed 4540 g or more at birth revealed an increased incidence of hyperglycemia (20.4% P less than 0.01). Only when a birth weight of more than the 99th percentile was considered was a significant association with maternal hyperglycemia evident. However, 105 of the 137 patients (77%) had normal glucose tolerance, which indicated that hyperglycemia is not necessarily the cause of fetal overgrowth. When a woman delivers an infant with a birth weight of 4540 g or more, it cannot be assumed that she was a gestational diabetic.

Nonimmunologic hydrops fetalis: a review of 61 cases.

Sixty-one cases of nonimmunologic hydrops fetalis were studied. The incidence of nonimmunologic hydrops fetalis, 1 in 3748 births, was unchanged in 2 decades. The mortality from nonimmunologic hydrops fetalis remained high (98%). Polyhydramnios (75%), anemia (45%), and preeclampsia (29%) were the commonest prenatal maternal complications, whereas postpartum hemorrhage or difficulty with placental delivery, or both, occurred in 64%. Ultrasound examination always was successful in detecting the hydropic state. Many presumed etiologic factors were noted, although in 38% no possible cause was found. A major congenital anomaly was present in 41%. The obstetric and neonatal care of nonimmunologic hydrops fetalis must be improved. If nonimmunologic hydrops fetalis is diagnosed during the investigation of polyhydramnios, consideration should be given to early delivery in the interest of the fetus.

Primary malignant fibrous histiocytoma of the uterus--ultrastructural and immunocytochemical studies of two cases.

The clinical and pathological features, including ultrastructural and immunocytochemical findings, of 2 cases of primary malignant fibrous histiocytoma of the uterus are reported. One patient had pulmonary metastases at the time of hysterectomy: she developed pelvic recurrence and died 3 mth after operation. The other patient was well and apparently free of disease 6 mth after hysterectomy. Histologically both tumours resembled pleomorphic leiomyosarcoma, and the diagnosis of a malignant fibrous histiocytoma was confirmed only after electron microscopic and immunocytochemical studies. Hormone receptor assay for estrogen and progesterone was positive in both tumours. Anti-estrogen treatment was started in one case but was ineffective.